These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 11112497

  • 1. Establishment of latent HIV-1 infection of resting CD4(+) T lymphocytes does not require inactivation of Vpr.
    Shen A, Siliciano JD, Pierson TC, Buck CB, Siliciano RF.
    Virology; 2000 Dec 05; 278(1):227-33. PubMed ID: 11112497
    [Abstract] [Full Text] [Related]

  • 2. Nuclear localization of Vpr is crucial for the efficient replication of HIV-1 in primary CD4+ T cells.
    Iijima S, Nitahara-Kasahara Y, Kimata K, Zhong Zhuang W, Kamata M, Isogai M, Miwa M, Tsunetsugu-Yokota Y, Aida Y.
    Virology; 2004 Oct 01; 327(2):249-61. PubMed ID: 15351213
    [Abstract] [Full Text] [Related]

  • 3. Could Nef and Vpr proteins contribute to disease progression by promoting depletion of bystander cells and prolonged survival of HIV-infected cells?
    Azad AA.
    Biochem Biophys Res Commun; 2000 Jan 27; 267(3):677-85. PubMed ID: 10673351
    [Abstract] [Full Text] [Related]

  • 4. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
    Li XD, Moore B, Cloyd MW.
    Virology; 1996 Nov 01; 225(1):196-212. PubMed ID: 8918547
    [Abstract] [Full Text] [Related]

  • 5. Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals.
    Chun TW, Justement JS, Lempicki RA, Yang J, Dennis G, Hallahan CW, Sanford C, Pandya P, Liu S, McLaughlin M, Ehler LA, Moir S, Fauci AS.
    Proc Natl Acad Sci U S A; 2003 Feb 18; 100(4):1908-13. PubMed ID: 12552096
    [Abstract] [Full Text] [Related]

  • 6. Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection.
    Blankson JN, Finzi D, Pierson TC, Sabundayo BP, Chadwick K, Margolick JB, Quinn TC, Siliciano RF.
    J Infect Dis; 2000 Dec 18; 182(6):1636-42. PubMed ID: 11069234
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Transactivation is a conserved function among primate lentivirus Vpr proteins but is not shared by Vpx.
    Philippon V, Matsuda Z, Essex M.
    J Hum Virol; 1999 Dec 18; 2(3):167-74. PubMed ID: 10413368
    [Abstract] [Full Text] [Related]

  • 9. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes.
    Connor RI, Chen BK, Choe S, Landau NR.
    Virology; 1995 Feb 01; 206(2):935-44. PubMed ID: 7531918
    [Abstract] [Full Text] [Related]

  • 10. Reservoirs of human immunodeficiency virus type 1: the main obstacles to viral eradication.
    Pomerantz RJ.
    Clin Infect Dis; 2002 Jan 01; 34(1):91-7. PubMed ID: 11731950
    [Abstract] [Full Text] [Related]

  • 11. In vitro reactivation of human immunodeficiency virus 1 from latently infected, resting CD4+ T cells after bacterial stimulation.
    Moriuchi H, Moriuchi M, Mizell SB, Ehler LA, Fauci AS.
    J Infect Dis; 2000 Jun 01; 181(6):2041-4. PubMed ID: 10837189
    [Abstract] [Full Text] [Related]

  • 12. Human immunodeficiency virus type 1 Vpr-dependent cell cycle arrest through a mitogen-activated protein kinase signal transduction pathway.
    Yoshizuka N, Yoshizuka-Chadani Y, Krishnan V, Zeichner SL.
    J Virol; 2005 Sep 01; 79(17):11366-81. PubMed ID: 16103188
    [Abstract] [Full Text] [Related]

  • 13. Simian immunodeficiency virus Vpr/Vpx proteins kill bystander noninfected CD4+ T-lymphocytes by induction of apoptosis.
    Bouzar AB, Villet S, Morin T, Rea A, Genestier L, Guiguen F, Garnier C, Mornex JF, Narayan O, Chebloune Y.
    Virology; 2004 Aug 15; 326(1):47-56. PubMed ID: 15262494
    [Abstract] [Full Text] [Related]

  • 14. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T, McArthur J, Siliciano RF.
    Annu Rev Immunol; 2000 Aug 15; 18():665-708. PubMed ID: 10837072
    [Abstract] [Full Text] [Related]

  • 15. Gene defects clustered at the C-terminus of the vpr gene of HIV-1 in long-term nonprogressing mother and child pair: in vivo evolution of vpr quasispecies in blood and plasma.
    Wang B, Ge YC, Palasanthiran P, Xiang SH, Ziegler J, Dwyer DE, Randle C, Dowton D, Cunningham A, Saksena NK.
    Virology; 1996 Sep 01; 223(1):224-32. PubMed ID: 8806556
    [Abstract] [Full Text] [Related]

  • 16. HIV-1 Vpr does not inhibit CTL-mediated apoptosis of HIV-1 infected cells.
    Lewinsohn DA, Lines R, Lewinsohn DM, Riddell SR, Greenberg PD, Emerman M, Bartz SR.
    Virology; 2002 Mar 01; 294(1):13-21. PubMed ID: 11886261
    [Abstract] [Full Text] [Related]

  • 17. Gelsolin segment 5 inhibits HIV-induced T-cell apoptosis via Vpr-binding to VDAC.
    Qiao H, McMillan JR.
    FEBS Lett; 2007 Feb 06; 581(3):535-40. PubMed ID: 17254575
    [Abstract] [Full Text] [Related]

  • 18. Activation of protein phosphatase-2A1 by HIV-1 Vpr cell death causing peptide in intact CD(4+) T cells and in vitro.
    Janoo A, Morrow PW, Tung HY.
    J Cell Biochem; 2005 Mar 01; 94(4):816-25. PubMed ID: 15578586
    [Abstract] [Full Text] [Related]

  • 19. TLR5 stimulation is sufficient to trigger reactivation of latent HIV-1 provirus in T lymphoid cells and activate virus gene expression in central memory CD4+ T cells.
    Thibault S, Imbeault M, Tardif MR, Tremblay MJ.
    Virology; 2009 Jun 20; 389(1-2):20-5. PubMed ID: 19447460
    [Abstract] [Full Text] [Related]

  • 20. Human immunodeficiency virus type 1 (HIV-1) Vpr-regulated cell death: insights into mechanism.
    Muthumani K, Choo AY, Premkumar A, Hwang DS, Thieu KP, Desai BM, Weiner DB.
    Cell Death Differ; 2005 Aug 20; 12 Suppl 1():962-70. PubMed ID: 15832179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.